PT96563A - Metodo para a preparacao de uma formulacao farmaceutica contendo um derivado de guanina - Google Patents

Metodo para a preparacao de uma formulacao farmaceutica contendo um derivado de guanina

Info

Publication number
PT96563A
PT96563A PT96563A PT9656391A PT96563A PT 96563 A PT96563 A PT 96563A PT 96563 A PT96563 A PT 96563A PT 9656391 A PT9656391 A PT 9656391A PT 96563 A PT96563 A PT 96563A
Authority
PT
Portugal
Prior art keywords
guanina
derived
preparation
formula containing
pharmaceutical formula
Prior art date
Application number
PT96563A
Other languages
English (en)
Other versions
PT96563B (pt
Inventor
Hazel-Anne Griffiths
Alan John Goodall
Joshua Oduro-Yeboah
Original Assignee
Beecham Group Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group Plc filed Critical Beecham Group Plc
Publication of PT96563A publication Critical patent/PT96563A/pt
Publication of PT96563B publication Critical patent/PT96563B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT96563A 1990-01-26 1991-01-24 Metodo para a preparacao de uma formulacao farmaceutica contendo um derivado de guanina PT96563B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909001886A GB9001886D0 (en) 1990-01-26 1990-01-26 Pharmaceutical formulation

Publications (2)

Publication Number Publication Date
PT96563A true PT96563A (pt) 1991-10-15
PT96563B PT96563B (pt) 1998-07-31

Family

ID=10669997

Family Applications (1)

Application Number Title Priority Date Filing Date
PT96563A PT96563B (pt) 1990-01-26 1991-01-24 Metodo para a preparacao de uma formulacao farmaceutica contendo um derivado de guanina

Country Status (29)

Country Link
EP (1) EP0511991B1 (pt)
JP (1) JP2545317B2 (pt)
KR (1) KR0170414B1 (pt)
CN (1) CN1056058C (pt)
AP (1) AP197A (pt)
AT (1) ATE142880T1 (pt)
AU (1) AU643975B2 (pt)
CA (1) CA2074503C (pt)
CY (2) CY1984A (pt)
DE (1) DE69122229T2 (pt)
DK (1) DK0511991T3 (pt)
ES (1) ES2092559T3 (pt)
FI (1) FI101600B1 (pt)
GB (1) GB9001886D0 (pt)
GR (1) GR3021385T3 (pt)
HK (1) HK218996A (pt)
HU (1) HU215842B (pt)
IE (1) IE910249A1 (pt)
IL (1) IL97008A (pt)
LU (1) LU90110I2 (pt)
MA (1) MA22051A1 (pt)
MY (1) MY110074A (pt)
PL (1) PL166678B1 (pt)
PT (1) PT96563B (pt)
SA (1) SA91110341B1 (pt)
SG (1) SG49144A1 (pt)
TW (1) TW307687B (pt)
WO (1) WO1991011187A1 (pt)
ZA (1) ZA91525B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9114939D0 (en) * 1991-07-11 1991-08-28 Smithkline Beecham Plc Pharmaceutical formulation
GB9326177D0 (en) * 1993-12-22 1994-02-23 Smithkline Beecham Plc Pharmaceuticals
US6124304A (en) * 1993-10-05 2000-09-26 Smithkline Beecham Plc Penciclovir for the treatment of zoster associated pain
GB9601544D0 (en) * 1996-01-26 1996-03-27 Smithkline Beecham Plc Pharmaceuticals
US7223387B2 (en) 1998-11-18 2007-05-29 Medivir Ab Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester
WO2017029298A1 (en) 2015-08-17 2017-02-23 Sanovel Ilac Sanayi Ve Ticaret A.S. A topical antiviral composition
US11364198B2 (en) 2018-04-05 2022-06-21 Bausch Health Ireland Limited Polymeric emulsion delivery systems

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1523865A (en) * 1974-09-02 1978-09-06 Wellcome Found Purine compunds and salts thereof
GB2080106B (en) * 1980-07-18 1984-03-07 Weelcome Foundation Ltd Acyclovin preparations
KR830005852A (ko) * 1980-07-18 1983-09-14 미첼 페터 잭슨 피부와 점막의 비루스 감염치료에 적합한 국소치료제의 제조방법
EP0095813A3 (en) * 1982-06-01 1985-05-08 THE PROCTER & GAMBLE COMPANY Penetrating topical pharmaceutical compositions containing 9-(2-hydroxyethoxymethyl) guanine
EP0141927B1 (en) * 1983-08-18 1991-10-30 Beecham Group Plc Antiviral guanine derivatives
IL73682A (en) * 1983-12-20 1991-08-16 Medivir Ab Antiviral pharmaceutical compositions containing 9-hydroxy aliphatic derivatives of guanine,some new such derivatives and process for their preparation
EP0152316B1 (en) * 1984-01-26 1989-07-26 Merck & Co. Inc. Substituted butyl guanines and their utilization in antiviral compositions
DE3671227D1 (de) * 1985-07-27 1990-06-21 Beecham Group Plc 9-substituierte guaninmonohydrate.

Also Published As

Publication number Publication date
KR0170414B1 (ko) 1999-02-18
SG49144A1 (en) 1998-05-18
HU9202431D0 (en) 1992-10-28
AP197A (en) 1992-06-30
DE69122229T2 (de) 1997-03-06
ES2092559T3 (es) 1996-12-01
GR3021385T3 (en) 1997-01-31
GB9001886D0 (en) 1990-03-28
AU7155891A (en) 1991-08-21
CA2074503C (en) 1999-12-14
ZA91525B (en) 1992-02-26
KR920703060A (ko) 1992-12-17
DK0511991T3 (da) 1996-11-11
CY1999020I2 (en) 2009-11-04
HK218996A (en) 1997-01-03
HU215842B (hu) 2001-02-28
MY110074A (en) 1997-12-31
TW307687B (pt) 1997-06-11
EP0511991A1 (en) 1992-11-11
EP0511991B1 (en) 1996-09-18
FI923371L (fi) 1992-07-24
AP9000236A0 (en) 1991-01-31
LU90110I2 (fr) 1997-09-25
JPH05503695A (ja) 1993-06-17
DE69122229D1 (de) 1996-10-24
PL166678B1 (pl) 1995-06-30
HUT62472A (en) 1993-05-28
IE910249A1 (en) 1991-07-31
CA2074503A1 (en) 1991-07-27
IL97008A0 (en) 1992-03-29
JP2545317B2 (ja) 1996-10-16
CN1056058C (zh) 2000-09-06
AU643975B2 (en) 1993-12-02
CN1053547A (zh) 1991-08-07
FI101600B (fi) 1998-07-31
FI923371A0 (fi) 1992-07-24
IL97008A (en) 1995-05-26
SA91110341B1 (ar) 2004-05-25
FI101600B1 (fi) 1998-07-31
WO1991011187A1 (en) 1991-08-08
MA22051A1 (fr) 1991-10-01
ATE142880T1 (de) 1996-10-15
PT96563B (pt) 1998-07-31
CY1984A (en) 1997-09-05

Similar Documents

Publication Publication Date Title
PT89276A (pt) Processo para a preparacao de uma formulacao farmaceutica de libertacao prolongada
PT87474A (pt) Process for the preparation of pharmaceutical compounds which contain ester 1-acetoxi-ethylic of cefuroxime
PT91731A (pt) Processo para a preparacao de composicoes farmaceuticas contendo ciclosporinas
MX9101179A (es) Procesos para la preparacion de compuestos carboxilados
PT97945A (pt) Processo para a preparacao de composicoes antimalarianas contendo benflumetol ederivados artemeter
DK163181C (da) Analogifremgangsmaade til fremstilling af n,n'-di(arylalkylen)alkylendiaminer eller farmaceutisk acceptable salte deraf
IS3814A (is) Aðferð til framleiðslu á lyfjablöndum
DK645788A (da) Anvendelse af ergolinderivater til fremstilling af et farmaceutisk praeparat
FI881064A7 (fi) Menetelmä tulehduksenvastaisten tai analgeettisten -aminoetyylisubstituoitujen fenyyliyhdisteiden valmistamiseksi
MX14533A (es) Procedimiento para la preparacion de compuestos farmaceuticos
EE9400257A (et) Kinoliin-3-karboksamiidi ühendi kasutamine ravimkompositsiooni valmistamiseks
FI912868A7 (fi) Menetelmä farmaseuttisten yhdisteiden valmistamiseksi
PT88682A (pt) A process for the preparation of pharmaceutical compositions containing a piperidinoalkanol-decongestant combination
FI98127B (fi) Menetelmä stabiloidun farmaseuttisen koostumuksen valmistamiseksi
PT88681A (pt) A process for the preparation of pharmaceutical compositions containing piperidinoalkanol derivatives
PT92922A (pt) Processo para a preparacao de composicoes farmaceuticas liquidas contendo derivados de piperidinoalcanol
DK386783A (da) Fremgangsmaade til fremstilling af benzamidderivater eller et farmaceutisk acceptabelt salt deraf
MX9101182A (es) Procesos para la preparacion de eteres ciclicos
FI101600B1 (fi) Menetelmä farmaseuttisen formulaation valmistamiseksi
PT87031A (pt) Process for the preparation of 4-phenylpiperidine compounds an d of pharmaceutical compositions therewith
DK651588D0 (da) Anvendelse af en forbindelse til fremstilling af et farmaceutisk praeparat til behandling af fibromyalgia
FI892144A7 (fi) Menetelmä 5-C-hydroksimetyylialdoheksoosipohjaisten yhdisteiden valmistamiseksi
PT89561A (pt) Processo para a preparacao de composicoes farmaceuticas contendo uma 4-aroilimidazol-2-ona
DK158675C (da) Analogifremgangsmaade til fremstilling af trialkylsiliciumholdige phenylcycloalkan-forbindelser ellerfarmaceutisk acceptable salte deraf
PT84465B (pt) Processo para a preparacao de uma composicao farmaceutica contendo (-)-eburnamonina

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19910618

FG3A Patent granted, date of granting

Effective date: 19980402

PC3A Transfer or assignment

Free format text: 20011115 NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD. BM

TE3A Change of address (patent)

Owner name: BEECHAM GROUP P.L.C.

Effective date: 20011115

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20130402